StopAfib.org has published the 2010 Most Popular Atrial Fibrillation News Stories and Videos List. Stroke prevention topped the list and included stories about warfarin (Coumadin) and alternatives such as dabigatran (Pradaxa) and rivaroxaban (Xarelto). Other popular topics included the new European atrial fibrillation guidelines, new antiarrhythmic medications, updates on catheter ablation and afib surgery, and [...]
Learn About Atrial Fibrillation (Afib) with a New Guide
Whether you’re an atrial fibrillation patient or caregiver, or are just interested in learning more about afib, check out the new Get Started Learning About Atrial Fibrillation Guide at StopAfib.org. You’ll find a wealth of information, including: what afib is and the problems it causes, including stroke and congestive heart failure information about an afib [...]
Dr. Peter Kowy: Atrial Fibrillation Drugs & Trials [StopAfib.org interview]
StopAfib.org interviews Dr. Peter Kowey See the full transcript at: www.stopafib.org In this video interview at Boston Atrial Fibrillation Symposium 2010, Dr. Peter Kowey talked about a number of exciting new things in the atrial fibrillation world, including the Cabana clinical trials, the Safari catheter ablation registry, dronedarone as a
Atrial Fibrillation Catheter Ablation Techniques–StopAfib.org interviews Dr. Vivek Reddy
In this video from Boston Atrial Fibrillation Symposium 2010, Dr. Vivek Reddy discusses some of the new atrial fibrillation catheter ablation technologies and also talks about non-pharmacological approaches to stroke prevention in afib, such as the Watchman and Lariat suture. Dr. Reddy is the Director of Electrophysiology at Mount Sinai
Atrial Fibrillation & Gender Differences–StopAfib.org interviews Dr. Andrea Russo
In this video interview at Boston Atrial Fibrillation Symposium 2010, Dr. Andrea Russo talks about gender differences in atrial fibrillation treatment and afib stroke risk in women. Dr. Russo is Director of Cardiac Ablation and Arrhythmia Services at Cooper University Hospital (New Jersey) and professor of medicine at Robert Wood
Are you at risk of bleeding from anticoagulants Coumadin or warfarin: New “HAS-BLED” tool assesses risk for those with atrial fibrillation
One of the most common questions we get centers around the use of anticoagulant drugs—either the brand drug, Coumadin, or the generic version, warfarin—and whether or not an atrial fibrillation patient should be on them. Anticoagulants decrease stroke risk, but can also increase bleeding risk. How do you sort it all out? It’s just as [...]
FDA Update on the WATCHMAN® Left Atrial Appendage (LAA) Closure Device to Prevent Strokes in Atrial Fibrillation Patients
There was an update today on the long-awaited FDA status of Atritech’s WATCHMAN® device. If approved, it would provide an alternative to taking Coumadin or warfarin to prevent strokes for those with atrial fibrillation. Here are some quotes from the press release. Minneapolis (March 18, 2010) — Atritech, Inc., an emerging medical device company, announced [...]
Gene Test Improves Coumadin (warfarin) Use for Stroke Prevention in Atrial Fibrillation (AF)
Genetic tests that show high or low sensitivity to blood thinner (anticoagulant) drugs like warfarin (Coumadin) not only improve dosing accuracy but also reduce hospitalization by 31%, according to a new study just presented at the American College of Cardiology scientific sessions. Coumadin is often prescribed for people who have afib to prevent blood clots [...]
